4577.T WACC - Weighted Average Cost of Capital

The WACC of Daito Pharmaceutical Co Ltd (4577.T) is 5.7%.

The Cost of Equity of Daito Pharmaceutical Co Ltd (4577.T) is 6.50%.

The Cost of Debt of Daito Pharmaceutical Co Ltd (4577.T) is 4.25%.

	Range	Selected
Cost of equity	5.40% - 7.60%	6.50%
Tax rate	29.60% - 30.10%	29.85%
Cost of debt	4.00% - 4.50%	4.25%
WACC	4.8% - 6.6%	5.7%

WACC

4577.T WACC calculation

Category	Low	High

Long-term bond rate	1.4%	1.9%
Equity market risk premium	6.1%	7.1%
Adjusted beta	0.65	0.73

Additional risk adjustments	0.0%	0.5%
Cost of equity	5.40%	7.60%

Tax rate	29.60%	30.10%
Debt/Equity ratio	0.29	0.29
Cost of debt	4.00%	4.50%

After-tax WACC	4.8%	6.6%


Selected WACC	5.7%

4577.T's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 4577.T:

cost_of_equity (6.50%) = risk_free_rate (1.65%) + equity_risk_premium (6.60%) * adjusted_beta (0.65) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.